http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2678093-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7fada561413fe96444fd3c6bfa206ec |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-02 |
| filingDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05d7ceb55e67bd22f28f8735764b5a14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2077c634769f1aabe44a07a789a64ad2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bbad3445d9a5c1ae413f8cd63ed9153 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_429a0a1dd6277711d05054b1cc68353a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9a4b32f9817dfe6ded68cef233fcbdc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_664540aeb85e4374be76299936a9bf16 |
| publicationDate | 2019-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2678093-C1 |
| titleOfInvention | Method for producing benzyldimethyl[3-(myristoylamino)-propyl]ammonium chloride monohydrate and pharmaceutical substance based thereon |
| abstract | FIELD: pharmaceuticals. n SUBSTANCE: invention relates to pharmaceutical chemistry, in particular to a method for producing benzyldimethyl[3-(myristoylamino)propyl]ammonium chloride monohydrate and a pharmaceutical substance based on it, which can be used for the production of medicinal, disinfectant and cosmetic preparations and creams with antiseptic action. Essence of the invention lies in the fact that benzyldimethyl[3-(myristoylamino)propyl]ammonium chloride (BDMPAC) monohydrate is obtained in two chemical stages – the reaction of myristic acid with 3-dimethylaminopropylamine followed by benzylation of the resulting 3-dimethylaminopropylamide myristic acid with benzyl chloride, which results in the desired BDMPAC monohydrate. Inventive method allows the process of obtaining the target BDMPAC monohydrate and pharmaceutical substances based on it without prior purification of the initial reagents and without isolation of intermediate products. n EFFECT: technical result is that the claimed method provides for obtaining high purity monohydrate BDMPAC with a high yield using a simple and safe technology with a significant reduction in the number of technological stages in comparison with the known methods. n 4 cl, 12 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2802627-C1 |
| priorityDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.